VFA
NBRV
Values First Advisors’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,262
| Closed | -$41.2K | – | 183 |
|
|
2023
Q2 | $41.2K | Buy |
27,262
+580
| +2% | +$876 | 0.02% | 161 |
|
|
2023
Q1 | $46.6K | Buy |
26,682
+814
| +3% | +$1.42K | 0.03% | 194 |
|
|
2022
Q4 | $48.9K | Sell |
25,868
-23
| -0.1% | -$43 | 0.03% | 147 |
|
|
2022
Q3 | $54K | Sell |
25,891
-17,837
| -41% | -$37.2K | 0.04% | 148 |
|
|
2022
Q2 | $8K | Sell |
43,728
-1,223
| -3% | -$224 | 0.01% | 153 |
|
|
2022
Q1 | $19K | Buy |
44,951
+6,565
| +17% | +$2.78K | 0.01% | 159 |
|
|
2021
Q4 | $23K | Sell |
38,386
-7,398
| -16% | -$4.43K | 0.01% | 166 |
|
|
2021
Q3 | $54K | Buy |
45,784
+1,588
| +4% | +$1.87K | 0.04% | 142 |
|
|
2021
Q2 | $60K | Sell |
44,196
-837
| -2% | -$1.14K | 0.04% | 143 |
|
|
2021
Q1 | $75K | Buy |
45,033
+2,725
| +6% | +$4.54K | 0.06% | 139 |
|
|
2020
Q4 | $102K | Sell |
42,308
-413,714
| -91% | -$997K | 0.08% | 139 |
|
|
2020
Q3 | $243K | Buy |
456,022
+52,649
| +13% | +$28.1K | 0.22% | 122 |
|
|
2020
Q2 | $272K | Sell |
403,373
-7,280
| -2% | -$4.91K | 0.27% | 110 |
|
|
2020
Q1 | $236K | Buy |
410,653
+195,340
| +91% | +$112K | 0.28% | 103 |
|
|
2019
Q4 | $284K | Buy |
+215,313
| New | +$284K | 0.27% | 106 |
|